You are here: vision-research.eu » News » Newsdetails: 23andMe given green light to sell DNA tests for...

Research

23andMe given green light to sell DNA tests for 10 diseases

April 17, 2017

The US Food and Drug Administration (FDA) has approved the first at-home genetic test that can help to determine a person’s risk of developing certain diseases.

Today’s long-awaited action allows the consumer-genetics firm 23andMe to market a test for 10 genetic conditions, including Alzheimer’s and Parkinson’s diseases, to consumers — and paves the way for a wave of do-it-yourself diagnostic tests. The company says that it will begin offering the new service in the coming months.


Missing some information on vision-research.eu?

* mandatory field